Abstract:Alzheimer's disease (AD) is the leading cause of dementia in the elderly and is characterized by memory loss and cognitive decline. Pathological hallmark of AD brains are intracellular neurofibrillary tangles and extracellular amyloid plaques. The major component of these plaques is the highly heterogeneous amyloid-β (Aβ) peptide, varying in length and modification. In recent years pyroglutamate-modified amyloid-β (pEAβ) peptides have increasingly moved into the focus since they have been described to be the predominant species of all N-terminally truncated Aβ. Compared to unmodified Aβ, pEAβ is known to show increased hydrophobicity, higher toxicity, faster aggregation and β-sheet stabilization and is more resistant to degradation. Nuclear magnetic resonance (NMR) spectroscopy is a particularly powerful method to investigate the conformations of pEAβ isoforms in solution and to study peptide/ligand interactions for drug development. However, biophysical characterization of pEAβ and comparison to its non-modified variant has so far been seriously hampered by the lack of highly pure recombinant and isotope-enriched protein. Here we present, to our knowledge, for the first time a reproducible protocol for the production of pEAβ from a recombinant precursor expressed in E. coli in natural isotope abundance as well as in uniformly [U-15N]- or [U-13C, 15N]-labeled form, with yields of up to 15 mg/l E. coli culture broth. The chemical state of the purified protein was evaluated by RP-HPLC and formation of pyroglutamate was verified by mass spectroscopy. The recombinant pyroglutamate-modified Aβ peptides showed characteristic sigmoidal aggregation kinetics as monitored by thioflavin-T assays. The quality and quantity of produced pEAβ40 and pEAβ42 allowed us to perform heteronuclear multidimensional NMR spectroscopy in solution and to sequence-specifically assign the backbone resonances under near-physiological conditions. Our results suggest that the presented method will be useful in obtaining cost-effective high-quality recombinant pEAβ40 and pEAβ42 for further physiological and biochemical studies.

Conformation of Pyroglutamated Amyloid β (3-40) and (11-40) Fibrils - Extended or Hairpin?

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Cross-Seeded Fibrillation Induced by Pyroglutamate-3 and Truncated Aβ40 Variants Leads to Aβ40 Structural Polymorphism Modulation and Elevated Toxicity.

Modulation of Aggregation and Structural Polymorphisms of Β-Amyloid Fibrils in Cellular Environments by Pyroglutamate-3 Variant Cross-Seeding.

Conformational Transition Of Amyloid Beta-Peptide

Dissecting the Behaviour of Β‐amyloid Peptide Variants During Oligomerization and Fibrillation

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Hairpin trimer transition state of amyloid fibril

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Amyloid‐β40 E22K fibril in familial Alzheimer's disease is more thermostable and susceptible to seeding

Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy

Varied Probability of Staying Collapsed/Extended at the Conformational Equilibrium of Monomeric Aβ 40 and Aβ 42

Molecular structure of an N-terminal phosphorylated β-amyloid fibril.

The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions.

Alzheimer Aβ Amyloid Annular Fibrils: Insight into Polymorphism

Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ <sub>16</sub> <sub>–</sub> <sub>22</sub> , Aβ <sub>16–35</sub> , and Aβ <sub>10</sub> <sub>–</sub> <sub>35</sub> ): Sequence effects

The structure of tyrosine-10 favors ionic conductance of Alzheimer's disease-associated full-length amyloid-β channels

Cryo-EM structures of lipidic fibrils of amyloid-β (1-40)

Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State

Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.

Aβ(1–42) Fibril Structure Illuminates Self-Recognition and Replication of Amyloid in Alzheimer's Disease